» Articles » PMID: 25407488

MiR-492 Contributes to Cell Proliferation and Cell Cycle of Human Breast Cancer Cells by Suppressing SOX7 Expression

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2014 Nov 20
PMID 25407488
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) have emerged as important regulators that potentially play critical roles in cancer cell biological processes. Previous studies have shown that miR-492 plays an important role in cell tumorigenesis in multiple kinds of human cancer cells. However, the underlying mechanisms of this microRNA in breast cancer remain largely unknown. In the present study, we investigated miR-492's role in cell proliferation of breast cancer. MiR-492 expression was markedly upregulated in breast cancer tissues and breast cancer cells. Overexpression of miR-492 promoted the proliferation and anchorage-independent growth of breast cancer cells. Bioinformatics analysis further revealed sex-determining region Y-box 7 (SOX7), a putative tumor suppressor, as a potential target of miR-492. Data from luciferase reporter assays showed that miR-492 directly binds to the 3'-untranslated region (3'-UTR) of SOX7 messenger RNA (mRNA) and repressed expression at both transcriptional and translational levels. Ectopic expression of miR-492 led to downregulation of SOX7 protein, which resulted in the upregulation of cyclin D1 and c-Myc. In functional assays, SOX7 silenced in miR-492-in-transfected ZR-75-30 cells has positive effect to promote cell proliferation, suggesting that direct SOX7 downregulation is required for miR-492-induced cell proliferation and cell cycle of breast cancer. In sum, these results suggest that miR-492 represents a potential onco-miR and participates in breast cancer carcinogenesis by suppressing SOX7 expression.

Citing Articles

The miR-1305/KLF5 negative regulatory loop affects pancreatic cancer cell proliferation and apoptosis.

Zhou Y, Tang Y, Huang F, Wang Z, Wen Z, Fang Q Hum Cell. 2025; 38(2):51.

PMID: 39921786 DOI: 10.1007/s13577-025-01173-3.


Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies.

Abdul Manap A, Wisham A, Wong F, Ahmad Najmi H, Ng Z, Diba R Front Cell Dev Biol. 2024; 12:1390704.

PMID: 38726321 PMC: 11079208. DOI: 10.3389/fcell.2024.1390704.


Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer.

Abbas Syed R, Davey M, Richard V, Miller N, Kerin M Int J Mol Sci. 2023; 24(16).

PMID: 37628874 PMC: 10454054. DOI: 10.3390/ijms241612694.


MicroRNAs as Potential Biomarkers in Gynecological Cancers.

Miskiewicz J, Mielczarek-Palacz A, Gola J Biomedicines. 2023; 11(6).

PMID: 37371799 PMC: 10296063. DOI: 10.3390/biomedicines11061704.


Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium.

Naser Al Deen N, Lanman N, Chittiboyina S, Fostok S, Nasr R, Lelievre S Sci Rep. 2022; 12(1):21974.

PMID: 36539576 PMC: 9768134. DOI: 10.1038/s41598-022-25663-8.


References
1.
Li P, Xie X, Chen Q, Pang G, Luo W, Tu J . MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-γ. Asian Pac J Cancer Prev. 2014; 15(16):6949-54. DOI: 10.7314/apjcp.2014.15.16.6949. View

2.
Zhi X, Tao J, Xie K, Zhu Y, Li Z, Tang J . MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. Cancer Lett. 2013; 346(1):104-13. DOI: 10.1016/j.canlet.2013.12.021. View

3.
Van Kouwenhove M, Kedde M, Agami R . MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011; 11(9):644-56. DOI: 10.1038/nrc3107. View

4.
Hui A, Lin A, Xu W, Waldron L, Perez-Ordonez B, Weinreb I . Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma. Clin Cancer Res. 2013; 19(8):2154-62. DOI: 10.1158/1078-0432.CCR-12-3572. View

5.
von Frowein J, Pagel P, Kappler R, von Schweinitz D, Roscher A, Schmid I . MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology. 2011; 53(3):833-42. DOI: 10.1002/hep.24125. View